As a dedicated engineer with a passion for innovation in the field of medical devices, telemedicine, and Artificial Intelligence, I have a diverse and international background. My journey in this field began with my PhD and postdoctoral research at Houston Methodist Hospital (Houston, Texas), where I had the privilege of contributing to the development of a novel implantable medical device for cell transplantation, covered by six international patents.After completing my Ph.D., my entrepreneurial spirit led me to establish a startup in Italy, Omnidermal Biomedics, which develops, manufactures, and distributes medical devices powered by AI for the diagnosis and monitoring of skin conditions. In 2019, Omnidermal received the Leonardo Award from the President of the Italian Republic as the best biomedical company. In 2020, Omnidermal began the commercialization of its first product in Italy and Europe. During the Covid outbreak, Omnidermal was selected and funded by the Italian government to develop and manufacture an emergency ventilator named ABU. Furthermore, Omnidermal received funding from the American Government through the INVEST program for its telemedical and emergency devices. This venture allowed me to leverage my technical expertise, deepen my understanding of business development, and establish valuable relationships with key opinion leaders in healthcare.Recently, under the guidance of distinguished leaders in pharmaceuticals, science, and business, I joined Continuity Biosciences as Senior Director for Platform Development and Strategy. Continuity is committed to pioneering advanced drug delivery technologies, including those I co-developed during my Ph.D. at Houston Methodist Hospital, to improve patient care and enhance therapy delivery. I am responsible for defining the business and regulatory strategy, supporting operational activities, and advancing these groundbreaking technologies through the FDA approval process to initiate clinical trials. This role allows me to build on my previous entrepreneurial and technical experiences to set new standards in the biopharmaceutical and medical technology landscapes.